Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

HCA vs UHS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
HCA
HCA Healthcare, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$96.01B
5Y Perf.+301.7%
UHS
Universal Health Services, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$10.55B
5Y Perf.+59.8%

HCA vs UHS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
HCA logoHCA
UHS logoUHS
IndustryMedical - Care FacilitiesMedical - Care Facilities
Market Cap$96.01B$10.55B
Revenue (TTM)$75.60B$17.76B
Net Income (TTM)$6.78B$1.52B
Gross Margin41.5%67.6%
Operating Margin15.8%11.5%
Forward P/E14.2x7.2x
Total Debt$50.20B$5.51B
Cash & Equiv.$1.04B$138M

HCA vs UHSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

HCA
UHS
StockMay 20May 26Return
HCA Healthcare, Inc. (HCA)100401.7+301.7%
Universal Health Se… (UHS)100159.8+59.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: HCA vs UHS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HCA leads in 5 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Universal Health Services, Inc. is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
HCA
HCA Healthcare, Inc.
The Income Pick

HCA carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 5 yrs, beta 0.29, yield 0.7%
  • 451.4% 10Y total return vs UHS's 30.4%
  • Lower volatility, beta 0.29, current ratio 0.83x
Best for: income & stability and long-term compounding
UHS
Universal Health Services, Inc.
The Growth Play

UHS is the clearest fit if your priority is growth exposure and valuation efficiency.

  • Rev growth 9.7%, EPS growth 37.3%, 3Y rev CAGR 9.0%
  • PEG 0.45 vs HCA's 0.68
  • 9.7% revenue growth vs HCA's 7.1%
Best for: growth exposure and valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthUHS logoUHS9.7% revenue growth vs HCA's 7.1%
ValueUHS logoUHSLower P/E (7.2x vs 14.2x), PEG 0.45 vs 0.68
Quality / MarginsHCA logoHCA9.0% margin vs UHS's 8.6%
Stability / SafetyHCA logoHCABeta 0.29 vs UHS's 0.60
DividendsHCA logoHCA0.7% yield, 5-year raise streak, vs UHS's 0.5%
Momentum (1Y)HCA logoHCA+21.2% vs UHS's -8.1%
Efficiency (ROA)HCA logoHCA11.3% ROA vs UHS's 9.8%, ROIC 19.9% vs 12.3%

HCA vs UHS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

HCAHCA Healthcare, Inc.
FY 2025
Managed Care And Other Insurers
50.5%$37.0B
Managed Medicare
18.4%$13.4B
Medicare
15.4%$11.3B
Medicaid
8.1%$5.9B
Managed Medicaid
5.0%$3.7B
International
2.5%$1.9B
UHSUniversal Health Services, Inc.
FY 2025
Acute Care Hospital Services
57.2%$9.9B
Behavioral Health Services
42.8%$7.4B

HCA vs UHS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHCALAGGINGUHS

Income & Cash Flow (Last 12 Months)

HCA leads this category, winning 4 of 6 comparable metrics.

HCA is the larger business by revenue, generating $75.6B annually — 4.3x UHS's $17.8B. Profitability is closely matched — net margins range from 9.0% (HCA) to 8.6% (UHS).

MetricHCA logoHCAHCA Healthcare, I…UHS logoUHSUniversal Health …
RevenueTrailing 12 months$75.6B$17.8B
EBITDAEarnings before interest/tax$15.5B$2.7B
Net IncomeAfter-tax profit$6.8B$1.5B
Free Cash FlowCash after capex$7.7B$894M
Gross MarginGross profit ÷ Revenue+41.5%+67.6%
Operating MarginEBIT ÷ Revenue+15.8%+11.5%
Net MarginNet income ÷ Revenue+9.0%+8.6%
FCF MarginFCF ÷ Revenue+10.2%+5.0%
Rev. Growth (YoY)Latest quarter vs prior year+6.7%+9.6%
EPS Growth (YoY)Latest quarter vs prior year+44.6%+17.7%
HCA leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

UHS leads this category, winning 6 of 6 comparable metrics.

At 7.3x trailing earnings, UHS trades at a 52% valuation discount to HCA's 15.1x P/E. Adjusting for growth (PEG ratio), UHS offers better value at 0.46x vs HCA's 0.72x — a lower PEG means you pay less per unit of expected earnings growth.

MetricHCA logoHCAHCA Healthcare, I…UHS logoUHSUniversal Health …
Market CapShares × price$96.0B$10.5B
Enterprise ValueMkt cap + debt − cash$145.2B$15.9B
Trailing P/EPrice ÷ TTM EPS15.13x7.29x
Forward P/EPrice ÷ next-FY EPS est.14.20x7.21x
PEG RatioP/E ÷ EPS growth rate0.72x0.46x
EV / EBITDAEnterprise value multiple9.37x6.09x
Price / SalesMarket cap ÷ Revenue1.27x0.61x
Price / BookPrice ÷ Book value/share1.47x
Price / FCFMarket cap ÷ FCF12.48x12.42x
UHS leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

HCA leads this category, winning 4 of 7 comparable metrics.

On the Piotroski fundamental quality scale (0–9), HCA scores 7/9 vs UHS's 6/9, reflecting strong financial health.

MetricHCA logoHCAHCA Healthcare, I…UHS logoUHSUniversal Health …
ROE (TTM)Return on equity+20.7%
ROA (TTM)Return on assets+11.3%+9.8%
ROICReturn on invested capital+19.9%+12.3%
ROCEReturn on capital employed+27.0%+16.0%
Piotroski ScoreFundamental quality 0–976
Debt / EquityFinancial leverage0.74x
Net DebtTotal debt minus cash$49.2B$5.4B
Cash & Equiv.Liquid assets$1.0B$138M
Total DebtShort + long-term debt$50.2B$5.5B
Interest CoverageEBIT ÷ Interest expense5.37x10.92x
HCA leads this category, winning 4 of 7 comparable metrics.

Total Returns (Dividends Reinvested)

HCA leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in HCA five years ago would be worth $21,107 today (with dividends reinvested), compared to $11,165 for UHS. Over the past 12 months, HCA leads with a +21.2% total return vs UHS's -8.1%. The 3-year compound annual growth rate (CAGR) favors HCA at 16.4% vs UHS's 6.1% — a key indicator of consistent wealth creation.

MetricHCA logoHCAHCA Healthcare, I…UHS logoUHSUniversal Health …
YTD ReturnYear-to-date-8.5%-23.3%
1-Year ReturnPast 12 months+21.2%-8.1%
3-Year ReturnCumulative with dividends+57.5%+19.3%
5-Year ReturnCumulative with dividends+111.1%+11.7%
10-Year ReturnCumulative with dividends+451.4%+30.4%
CAGR (3Y)Annualised 3-year return+16.4%+6.1%
HCA leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

HCA leads this category, winning 2 of 2 comparable metrics.

HCA is the less volatile stock with a 0.29 beta — it tends to amplify market swings less than UHS's 0.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HCA currently trades 77.2% from its 52-week high vs UHS's 68.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricHCA logoHCAHCA Healthcare, I…UHS logoUHSUniversal Health …
Beta (5Y)Sensitivity to S&P 5000.29x0.60x
52-Week HighHighest price in past year$556.52$246.33
52-Week LowLowest price in past year$330.00$152.33
% of 52W HighCurrent price vs 52-week peak+77.2%+68.4%
RSI (14)Momentum oscillator 0–10030.335.2
Avg Volume (50D)Average daily shares traded1.0M791K
HCA leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

HCA leads this category, winning 2 of 2 comparable metrics.

Wall Street rates HCA as "Buy" and UHS as "Hold". Consensus price targets imply 37.4% upside for UHS (target: $232) vs 22.8% for HCA (target: $527). For income investors, HCA offers the higher dividend yield at 0.69% vs UHS's 0.47%.

MetricHCA logoHCAHCA Healthcare, I…UHS logoUHSUniversal Health …
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$527.45$231.50
# AnalystsCovering analysts4643
Dividend YieldAnnual dividend ÷ price+0.7%+0.5%
Dividend StreakConsecutive years of raises51
Dividend / ShareAnnual DPS$2.94$0.80
Buyback YieldShare repurchases ÷ mkt cap+10.5%+9.2%
HCA leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

HCA leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). UHS leads in 1 (Valuation Metrics).

Best OverallHCA Healthcare, Inc. (HCA)Leads 5 of 6 categories
Loading custom metrics...

HCA vs UHS: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is HCA or UHS a better buy right now?

For growth investors, Universal Health Services, Inc.

(UHS) is the stronger pick with 9. 7% revenue growth year-over-year, versus 7. 1% for HCA Healthcare, Inc. (HCA). Universal Health Services, Inc. (UHS) offers the better valuation at 7. 3x trailing P/E (7. 2x forward), making it the more compelling value choice. Analysts rate HCA Healthcare, Inc. (HCA) a "Buy" — based on 46 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — HCA or UHS?

On trailing P/E, Universal Health Services, Inc.

(UHS) is the cheapest at 7. 3x versus HCA Healthcare, Inc. at 15. 1x. On forward P/E, Universal Health Services, Inc. is actually cheaper at 7. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Universal Health Services, Inc. wins at 0. 45x versus HCA Healthcare, Inc. 's 0. 68x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — HCA or UHS?

Over the past 5 years, HCA Healthcare, Inc.

(HCA) delivered a total return of +111. 1%, compared to +11. 7% for Universal Health Services, Inc. (UHS). Over 10 years, the gap is even starker: HCA returned +451. 4% versus UHS's +30. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — HCA or UHS?

By beta (market sensitivity over 5 years), HCA Healthcare, Inc.

(HCA) is the lower-risk stock at 0. 29β versus Universal Health Services, Inc. 's 0. 60β — meaning UHS is approximately 111% more volatile than HCA relative to the S&P 500.

05

Which is growing faster — HCA or UHS?

By revenue growth (latest reported year), Universal Health Services, Inc.

(UHS) is pulling ahead at 9. 7% versus 7. 1% for HCA Healthcare, Inc. (HCA). On earnings-per-share growth, the picture is similar: Universal Health Services, Inc. grew EPS 37. 3% year-over-year, compared to 29. 0% for HCA Healthcare, Inc.. Over a 3-year CAGR, UHS leads at 9. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — HCA or UHS?

HCA Healthcare, Inc.

(HCA) is the more profitable company, earning 9. 0% net margin versus 8. 6% for Universal Health Services, Inc. — meaning it keeps 9. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCA leads at 15. 8% versus 11. 5% for UHS. At the gross margin level — before operating expenses — UHS leads at 90. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is HCA or UHS more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Universal Health Services, Inc. (UHS) is the more undervalued stock at a PEG of 0. 45x versus HCA Healthcare, Inc. 's 0. 68x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Universal Health Services, Inc. (UHS) trades at 7. 2x forward P/E versus 14. 2x for HCA Healthcare, Inc. — 7. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UHS: 37. 4% to $231. 50.

08

Which pays a better dividend — HCA or UHS?

All stocks in this comparison pay dividends.

HCA Healthcare, Inc. (HCA) offers the highest yield at 0. 7%, versus 0. 5% for Universal Health Services, Inc. (UHS).

09

Is HCA or UHS better for a retirement portfolio?

For long-horizon retirement investors, HCA Healthcare, Inc.

(HCA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 29), 0. 7% yield, +451. 4% 10Y return). Both have compounded well over 10 years (HCA: +451. 4%, UHS: +30. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between HCA and UHS?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

HCA pays a dividend while UHS does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

HCA

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

UHS

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform HCA and UHS on the metrics below

Revenue Growth>
%
(HCA: 6.7% · UHS: 9.6%)
Net Margin>
%
(HCA: 9.0% · UHS: 8.6%)
P/E Ratio<
x
(HCA: 15.1x · UHS: 7.3x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.